Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Comment by TechnicalBuyon Jan 22, 2014 5:21pm

238 Views

Post# 22122520

RE:RE:Talk with Meekison

Andrew's a smart guy. I'd say the timing was good too. Better to do the financing now, rather than two months down the road when the buying frenzy is in full bloom. The selling was probably from folks who either thought they could get in on the financing, or gypsy swapping from the group that has already bought some from the US. Who knows...perhpas the push from the US was already pre-arranged as part of the pp...remember it's the US buying that got us to high .50s anyway.

TB
https://twitter.com/technicalbuy

Bullboard Posts

Canadian artificial intelligence ETFs